http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2015029967-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55594 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate | 2014-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2015029967-A1 |
| titleOfInvention | Antibody titer using lactic acid bacteria |
| abstract | An object of the present invention is to increase an antibody titer that maintains an effect based on inoculation of a vaccine, for example, an adjuvant, an antibody titer that is safe, simple, economical, and can be easily ingested regardless of generation, For example, an adjuvant and a method for producing the same are provided. The present invention contains a method for increasing antibody titer, a method for enhancing the vaccine effect using Lactobacillus delbrueckii subspecies bulgaricus OLL1073R-1 or a culture thereof, and a method for enhancing the vaccine effect, and Lactobacillus delbrueckii subspecies bulgaricus OLL1073R-1 or a culture thereof The present invention relates to an antibody titer, for example, an adjuvant. |
| priorityDate | 2013-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.